NCT06891222View on ClinicalTrials.gov

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

RecruitingOBSERVATIONAL
Enrollment

10,500

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Cardiac Disease
Interventions
DIAGNOSTIC_TEST

AI-ECG (artificial intelligence-enabled electrocardiogram)

Participants will undergo electrocardiogram analysis using AI-ECG during the baseline visit

DIAGNOSTIC_TEST

Focus Screening (focused cardiac ultrasonography)

Participants will undergo a focused cardiac ultrasound if the AI-ECG reflects a positive value

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06891222 - A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening | Biotech Hunter | Biotech Hunter